SCHEMBL27537460

SCHEMBL27537460

CC(C)COC(=O)NC(CC(N)=O)C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
PSMB1 P20618 1/20 0.36
TSHR P16473 5/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CACNA1B Q00975 1/20 0.34
HTT P42858 2/20 0.34
LMNA P02545 1/20 0.34
ALOX15 P16050 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TACR1 P25103 1/20 0.34
NMBR P28336 1/20 0.34
CTSL P07711 1/20 0.33
CTSB P07858 1/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6046082 1.00 ECE1 (0.45) ECE1SMN1; SMN2PSMB1TSHRMAPT
SCHEMBL7883345 0.84 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1CTSLCTSBCTSS
SCHEMBL7347883 0.82 ECE1 (0.44) ECE1SMN1; SMN2TSHRALDH1A1MAPK1
SCHEMBL7352891 0.82 ECE1 (0.44) ECE1SMN1; SMN2TSHRALDH1A1MAPK1
SCHEMBL7359411 0.79 PSMB1 (0.44) ECE1PSMB1CTSLCTSSCTSK
SCHEMBL21663698 0.76 CYP1A2 (0.46) SMN1; SMN2HTTCTSLCTSBCTSS
SCHEMBL18190841 0.76 FOLH1 (0.51) SMN1; SMN2
SCHEMBL21538566 0.76 FOLH1 (0.51) SMN1; SMN2
SCHEMBL27668713 0.75 SMN1; SMN2 (0.46) ECE1SMN1; SMN2TSHRMAPTKDM4E
SCHEMBL27668711 0.75 SMN1; SMN2 (0.46) ECE1SMN1; SMN2TSHRMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1268117-A Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis DU PONT PHARM CO (US) 2000-09-27 CN disclosed